Chemfab Alkalis Limited: AGM Concludes Successfully with All Resolutions Passed
Chemfab Alkalis Limited's AGM on September 9, 2026, passed all resolutions. Key decisions include adopting FY26 financial statements, re-appointing a director, declaring a dividend of ₹1.25 per share, appointing auditors for five years, and approving director remuneration.
The passing of resolutions regarding financial statements, dividend declaration, auditor appointments, and director remuneration are material to the company's governance and financial operations, impacting shareholder value and regulatory compliance.
All resolutions presented at the AGM were passed with the requisite majority, indicating shareholder approval and confidence in the company's decisions and management.
Chemfab Alkalis Limited has submitted the voting results and the Scrutinizer's Report for its Annual General Meeting (AGM) held on September 9, 2026. The meeting, conducted via Video Conferencing (VC)/Other Audio Visual Means (OAVM), saw all resolutions presented to the shareholders being passed with the requisite majority.
The resolutions included the adoption of the Audited Standalone and Consolidated Financial Statements for the year ended March 31, 2026. Shareholders also re-appointed Mr. Suresh Krishnamurthi Rao as a Director retiring by rotation. A dividend of ₹1.25 per Equity Share (12.50%) was declared, payable to members on record as of the book closure date.
Furthermore, M/s. M S K C & Associates LLP were appointed as Statutory Auditors for a term of five years, from the conclusion of the 17th AGM until the conclusion of the 22nd AGM. The remuneration of M/s. Madhavan, Mohan & Associates as Cost Auditors for the Financial Year 2026-27 was ratified at Rs. 1,90,000. Shareholders also accorded consent for the payment of commission to Non-Executive Directors, not exceeding 11% of the net profits, and for specific conditions related to independent directors' remuneration as per SEBI regulations.
What to do with a filing like this
Chemfab Alkalis Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Chemfab Alkalis Limited. Read the original for the full detail.